NCT02281396

The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans

A Safety Study of Freeze-dried Rabies Vaccine(MRC-5 Cell)in Chinese Humans From 10-60 Years Old

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Beijing Center for Disease Control and Prevention · Other Government
• Sex: All
• Age: 10 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the safety of Freeze-dried Rabies Vaccine （MRC-5 Cell) in healthy humans aged from 10-60 years old, according to the traditional Essen methods (1-1-1-1-1) vaccination.

Conditions

• Rabies
• Healthy

Interventions

Type	Name	Description
BIOLOGICAL	2.5IU/ml in rabies vaccine （MRC-5 Cell) humans aged 10-20 years old	Freeze-dried Rabies Vaccine（MRC-5 Cell) of 2.5IU/ml,5 doses,4 weeks interval
BIOLOGICAL	2.5IU/ml rabies vaccine （MRC-5 Cell) in humans aged 21-60 years old	Freeze-dried Rabies Vaccine（MRC-5 Cell) of 2.5IU/ml,5 doses,4 weeks interval
BIOLOGICAL	2.5IU/ml rabies vaccine （MRC-5 Cell) in humans(from 10-20 years old)	Freeze-dried Rabies Vaccine（vero Cell) of 2.5IU/ml,5 doses,4 weeks interval
BIOLOGICAL	2.5IU/ml rabies vaccine （MRC-5 Cell) in humans(from 21-60 years old)	Freeze-dried Rabies Vaccine（vero Cell) of 2.5IU/ml,5 doses,4 weeks interval

Timeline

• Start date: 2014-11-01
• Primary completion: 2015-01-01
• Completion: 2015-05-01
• First posted: 2014-11-03
• Last updated: 2016-01-20